MariMed Balance Sheet Health
Financial Health criteria checks 2/6
MariMed has a total shareholder equity of $86.8M and total debt of $75.5M, which brings its debt-to-equity ratio to 86.9%. Its total assets and total liabilities are $212.7M and $125.8M respectively. MariMed's EBIT is $7.6M making its interest coverage ratio 1.2. It has cash and short-term investments of $9.8M.
Key information
86.9%
Debt to equity ratio
US$75.49m
Debt
| Interest coverage ratio | 1.2x |
| Cash | US$9.79m |
| Equity | US$86.84m |
| Total liabilities | US$125.84m |
| Total assets | US$212.68m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MRMD's short term assets ($56.7M) exceed its short term liabilities ($44.6M).
Long Term Liabilities: MRMD's short term assets ($56.7M) do not cover its long term liabilities ($81.2M).
Debt to Equity History and Analysis
Debt Level: MRMD's net debt to equity ratio (75.7%) is considered high.
Reducing Debt: MRMD's debt to equity ratio has increased from 42% to 86.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MRMD has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MRMD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.